This IPO Deserves a SPAC(E) in Your Portfolio

Special purpose acquisition companies (SPACs) are all the rage right now.
However, you must be careful which ones you invest in. Some are fly-by-night companies that were created to enrich the managers of the fund. Others are legitimate ventures, where the goal is for the manager to prosper with you.
A good example of the latter is DraftKings (Nasdaq: DKNG), a position that War Room members are in right now and making money with. DraftKings – as we have written about in these very pages – has a lock on the iGaming market, with the goal of letting you bet on almost anything from anywhere.
But that’s not what I am introducing you to today.
Yesterday, a new SPAC became public…
Before I get to it, here is a great explanation of a SPAC from Investopedia:
A special purpose acquisition company (SPAC) is a company with no commercial operations that is formed strictly to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. Also known as “blank check companies,” SPACs have been around for decades. In recent years, they’ve gone mainstream, attracting big-name underwriters and investors and raising a record amount of IPO money in 2019.
Here are the key takeaways:
- A SPAC is formed to raise money through an initial public offering (IPO) to buy another company.
- At the time of its IPO, a SPAC has no existing business operations or even stated targets for acquisition.
- Investors in SPACs can range from well-known private equity funds to the public.
- SPACs have two years to complete an acquisition or will be required to return the funds to investors.
That said, Bill Ackman, hedge fund manager and CEO of Pershing Square, brought a SPAC public yesterday called Pershing Square Tontine Holdings, which trades on the New York Stock Exchange with the symbol PSTH.U or PSTHU. (You’ll need to check with your broker for the exact symbol used – and don’t mistake it for Pershing Square’s own stock.)
The SPAC went public at $20 with 200 million shares issued. The kicker is that the money raised, all $4 billion, goes into the SPAC and not some promoter’s pocket. And Pershing Square will invest between $1 billion to $3 billion more into the fund.
I like it when the manager has so much skin in the game and is not charging huge fees. The interests between all the parties are aligned!
But let’s not jump the gun. While the SPAC is now up and running, it still must find good investments, and that takes time. SPACs must find those investments within a two-year period, otherwise the money is supposed to be returned to the shareholders.
Action Plan: This “time” allows members to position themselves into this SPAC at the price they want. And that is exactly what they’re doing in The War Room right now.
So sign up for The War Room right now and join me to get all the details on how to buy this particular SPAC before it has the chance to hit pay dirt!
The post This IPO Deserves a SPAC(E) in Your Portfolio appeared first on Investment U.
Founded in 1999, the goal of Investment U is to give you impartial, no-nonsense investment advice and investment research on how to build long-lasting wealth.
Source: https://investmentu.com/spac-ipo-investment/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

